Cargando…
2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary
Cancer of unknown primary (CUP) is defined as a heterogeneous group of tumours that present with metastasis, and in which attempts to identify the original site have failed. They differ from other primary tumours in their biological features and how they spread, which means that they can be consider...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182632/ https://www.ncbi.nlm.nih.gov/pubmed/29808414 http://dx.doi.org/10.1007/s12094-018-1899-z |
_version_ | 1783362610720145408 |
---|---|
author | Losa, F. Iglesias, L. Pané, M. Sanz, J. Nieto, B. Fusté, V. de la Cruz-Merino, L. Concha, Á. Balañá, C. Matías-Guiu, X. |
author_facet | Losa, F. Iglesias, L. Pané, M. Sanz, J. Nieto, B. Fusté, V. de la Cruz-Merino, L. Concha, Á. Balañá, C. Matías-Guiu, X. |
author_sort | Losa, F. |
collection | PubMed |
description | Cancer of unknown primary (CUP) is defined as a heterogeneous group of tumours that present with metastasis, and in which attempts to identify the original site have failed. They differ from other primary tumours in their biological features and how they spread, which means that they can be considered a separate entity. There are several hypotheses regarding their origin, but the most plausible explanation for their aggressiveness and chemoresistance seems to involve chromosomal instability. Depending on the type of study done, CUP can account for 2–9% of all cancer patients, mostly 60–75 years old. This article reviews the main clinical, pathological, and molecular studies conducted to analyse and determine the origin of CUP. The main strategies for patient management and treatment, by both clinicians and pathologists, are also addressed. |
format | Online Article Text |
id | pubmed-6182632 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-61826322018-10-24 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary Losa, F. Iglesias, L. Pané, M. Sanz, J. Nieto, B. Fusté, V. de la Cruz-Merino, L. Concha, Á. Balañá, C. Matías-Guiu, X. Clin Transl Oncol Review Article Cancer of unknown primary (CUP) is defined as a heterogeneous group of tumours that present with metastasis, and in which attempts to identify the original site have failed. They differ from other primary tumours in their biological features and how they spread, which means that they can be considered a separate entity. There are several hypotheses regarding their origin, but the most plausible explanation for their aggressiveness and chemoresistance seems to involve chromosomal instability. Depending on the type of study done, CUP can account for 2–9% of all cancer patients, mostly 60–75 years old. This article reviews the main clinical, pathological, and molecular studies conducted to analyse and determine the origin of CUP. The main strategies for patient management and treatment, by both clinicians and pathologists, are also addressed. Springer International Publishing 2018-05-28 2018 /pmc/articles/PMC6182632/ /pubmed/29808414 http://dx.doi.org/10.1007/s12094-018-1899-z Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Article Losa, F. Iglesias, L. Pané, M. Sanz, J. Nieto, B. Fusté, V. de la Cruz-Merino, L. Concha, Á. Balañá, C. Matías-Guiu, X. 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary |
title | 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary |
title_full | 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary |
title_fullStr | 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary |
title_full_unstemmed | 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary |
title_short | 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary |
title_sort | 2018 consensus statement by the spanish society of pathology and the spanish society of medical oncology on the diagnosis and treatment of cancer of unknown primary |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182632/ https://www.ncbi.nlm.nih.gov/pubmed/29808414 http://dx.doi.org/10.1007/s12094-018-1899-z |
work_keys_str_mv | AT losaf 2018consensusstatementbythespanishsocietyofpathologyandthespanishsocietyofmedicaloncologyonthediagnosisandtreatmentofcancerofunknownprimary AT iglesiasl 2018consensusstatementbythespanishsocietyofpathologyandthespanishsocietyofmedicaloncologyonthediagnosisandtreatmentofcancerofunknownprimary AT panem 2018consensusstatementbythespanishsocietyofpathologyandthespanishsocietyofmedicaloncologyonthediagnosisandtreatmentofcancerofunknownprimary AT sanzj 2018consensusstatementbythespanishsocietyofpathologyandthespanishsocietyofmedicaloncologyonthediagnosisandtreatmentofcancerofunknownprimary AT nietob 2018consensusstatementbythespanishsocietyofpathologyandthespanishsocietyofmedicaloncologyonthediagnosisandtreatmentofcancerofunknownprimary AT fustev 2018consensusstatementbythespanishsocietyofpathologyandthespanishsocietyofmedicaloncologyonthediagnosisandtreatmentofcancerofunknownprimary AT delacruzmerinol 2018consensusstatementbythespanishsocietyofpathologyandthespanishsocietyofmedicaloncologyonthediagnosisandtreatmentofcancerofunknownprimary AT conchaa 2018consensusstatementbythespanishsocietyofpathologyandthespanishsocietyofmedicaloncologyonthediagnosisandtreatmentofcancerofunknownprimary AT balanac 2018consensusstatementbythespanishsocietyofpathologyandthespanishsocietyofmedicaloncologyonthediagnosisandtreatmentofcancerofunknownprimary AT matiasguiux 2018consensusstatementbythespanishsocietyofpathologyandthespanishsocietyofmedicaloncologyonthediagnosisandtreatmentofcancerofunknownprimary |